The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers :
hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992.

Description

Corporate Author

United States. Congress.

Language(s)

English

Published

Washington : U.S. G.P.O. : 1993.

Subjects

Mifepristone.
Import quotas > Import quotas / United States.
Medicine > Medicine / Research > Medicine / Research / United States.
Pharmaceutical policy > Pharmaceutical policy / United States.
Mifepristone > Mifepristone / Government policy > Mifepristone / Government policy / United States.

Note

"Serial no. 102-85."
Shipping list no.: 93-0175-P.
Distributed to some depository libraries in microfiche.

Physical Description

iv, 144 p. : ill. ; 24 cm.

ISBN

0160399661

Locate a Print Version

Find in a library

Viewability